ATRS Antares Pharma Inc

USD 5.59 0.00 0
Icon

Antares Pharma Inc (ATRS) Stock Analysis and Price Targets

COMMON STOCK | Pharmaceuticals | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 5.59

0.00 (0.00)%

USD 0.96B

N/A

N/A

N/A

Icon

ATRS

Antares Pharma Inc (USD)
COMMON STOCK | NSD
USD 5.59
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.96B

N/A

USD 5.59

Antares Pharma Inc (ATRS) Stock Forecast

N/A

Based on the Antares Pharma Inc stock forecast from 0 analysts, the average analyst target price for Antares Pharma Inc is not available over the next 12 months. Antares Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Antares Pharma Inc is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Antares Pharma Inc’s stock price was USD 5.59. Antares Pharma Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Antares Pharma Inc
No recent average analyst rating found for Antares Pharma Inc

Company Overview Antares Pharma Inc

Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. It develops, manufactures, and commercializes novel therapeut...Read More

100 Princeton South, Ewing, NJ, United States, 08628

201

December

USD

USA

Adjusted Closing Price for Antares Pharma Inc (ATRS)

Loading...

Unadjusted Closing Price for Antares Pharma Inc (ATRS)

Loading...

Share Trading Volume for Antares Pharma Inc Shares

Loading...

Compare Performance of Antares Pharma Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ATRS

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Antares Pharma Inc (Sector: Pharmaceuticals )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZGNX
Zogenix Inc 0.00 (0.00%) USD1.50B N/A N/A

ETFs Containing ATRS

Symbol Name ATRS's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Antares Pharma Inc (ATRS) Stock

Stock Target Advisor's fundamental analysis for Antares Pharma Inc's stock is Very Bullish.

Unfortunately we do not have enough data on ATRS's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ATRS's stock to indicate what its average analyst target is.

ATRS stock's Price/Earning ratio is 24.09. Based on this ATRS may be undervalued for its sector.

The last closing price of ATRS's stock was USD 5.59.

The most recent market capitalization for ATRS is USD 0.96B.

Unfortunately we do not have enough analyst data on ATRS's stock to indicate whether its price will go up or not.

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $etfs_link

Filename: stock-details/faqs.php

Line Number: 256

Backtrace:

File: /var/www/html/stocktarget/application/views/stock-details/faqs.php
Line: 256
Function: _error_handler

File: /var/www/html/stocktarget/application/views/stock-details/stock-detailss.php
Line: 2400
Function: include

File: /var/www/html/stocktarget/application/controllers/Stock_details.php
Line: 853
Function: view

File: /var/www/html/stocktarget/index.php
Line: 322
Function: require_once

We can't find any ETFs which contains Antares Pharma Inc's stock.

As per our most recent records Antares Pharma Inc has 201 Employees.

Antares Pharma Inc's registered address is 100 Princeton South, Ewing, NJ, United States, 08628. You can get more information about it from Antares Pharma Inc's website at https://www.antarespharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...